{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:55:21Z","timestamp":1792896921243,"version":"4.5.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1161521)"],"award-info":[{"award-number":["1161521)"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recipients of allogeneic hematopoietic cell transplantation (alloHCT) are at risk of multiple viral infections. However, our knowledge about the clinical impact of viruses following alloHCT is predominantly focused on outcomes of a single viral infection such as cytomegalovirus (CMV). This retrospective cohort study aimed to evaluate the incidence, risk factors, and clinical outcomes of multiple viral infections in the first year following alloHCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All microbiologically confirmed viral infection of CMV, Epstein-Barr virus (EBV), BK polyomavirus (BKV), varicella zoster virus, human herpesvirus 6, herpes simplex virus, and various respiratory viruses were reviewed up to 12 months post-alloHCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 430 alloHCT recipients, 744 viral infections were observed within the first year posttransplantation, predominantly CMV (55%), followed by EBV (51%) and BKV (21%). Eighty-five percent of patients had at least 1 viral infection, of which 34% had 2 and 24% had \u22653 viruses. Independent risk factors of multiple viral infections included CMV serostatus (R+\/D\u2212: hazard ratio [HR], 2.59 [95% confidence interval {CI}, 2.03\u20133.30]; R\u2212\/D+: HR, 2.25 [95% CI, 1.66\u20133.05]), haploidentical donor (HR, 1.56 [95% CI, 1.18\u20132.06]), T-cell depletion use (HR, 1.44 [95% CI, 1.11\u20131.88]), and grade III\u2013IV acute graft-versus-host disease (HR, 1.44 [95% CI, 1.15\u20131.80]). Patients experiencing multiple viral infections (\u22653 vs 2 vs 1) had an earlier time to onset of first infection (median, 18 vs 25 vs 40 days), were hospitalized for an increased number of days (median, 53 vs 40 vs 37 days), and had lower survival probability at day 270 following infusion (P = .044).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multiple viral infections were frequently observed, with a significant impact on morbidity and mortality following alloHCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf597","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:06:47Z","timestamp":1758888407000},"source":"Crossref","is-referenced-by-count":6,"title":["Incidence and Clinical Outcomes of Multiple Viral Infections After Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8888-1648","authenticated-orcid":false,"given":"Kar Yee","family":"Yong","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne ,","place":["Australia"]},{"name":"National Centre for Infections in Cancer , Infectious Diseases Unit, Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shio Yen","family":"Tio","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne ,","place":["Australia"]},{"name":"National Centre for Infections in Cancer , Infectious Diseases Unit, Melbourne ,","place":["Australia"]},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital , Melbourne ,","place":["Australia"]},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Z","family":"Sim","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne ,","place":["Australia"]},{"name":"National Centre for Infections in Cancer , Infectious Diseases Unit, Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Sasadeusz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Royal Melbourne Hospital , Melbourne ,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3956-7335","authenticated-orcid":false,"given":"Alex","family":"Rivalland","sequence":"additional","affiliation":[{"name":"Clinical Hematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4250-4448","authenticated-orcid":false,"given":"Lynette","family":"Chee","sequence":"additional","affiliation":[{"name":"Clinical Hematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-2301","authenticated-orcid":false,"given":"Jeff","family":"Szer","sequence":"additional","affiliation":[{"name":"Clinical Hematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9204-3216","authenticated-orcid":false,"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Peter MacCallum Cancer Centre , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-314X","authenticated-orcid":false,"given":"Monica","family":"Slavin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne ,","place":["Australia"]},{"name":"National Centre for Infections in Cancer , Infectious Diseases Unit, Melbourne ,","place":["Australia"]},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital , Melbourne ,","place":["Australia"]},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ritchie","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne , Melbourne ,","place":["Australia"]},{"name":"Clinical Hematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-4145","authenticated-orcid":false,"given":"Michelle K","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , Melbourne ,","place":["Australia"]},{"name":"National Centre for Infections in Cancer , Infectious Diseases Unit, Melbourne ,","place":["Australia"]},{"name":"Department of Infectious Diseases, Royal Melbourne Hospital , Melbourne ,","place":["Australia"]},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2025102314031200100_ofaf597-B1","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/infdis\/jix192","article-title":"Identifying cytomegalovirus complications using the Quantiferon-CMV assay after allogeneic hematopoietic stem cell transplantation","volume":"215","author":"Yong","year":"2017","journal-title":"J Infect Dis"},{"key":"2025102314031200100_ofaf597-B2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3389\/fimmu.2018.01672","article-title":"Mass cytometry for the assessment of immune reconstitution after hematopoietic stem cell transplantation","volume":"9","author":"Stern","year":"2018","journal-title":"Front Immunol"},{"key":"2025102314031200100_ofaf597-B3","doi-asserted-by":"crossref","first-page":"818167","DOI":"10.3389\/fcimb.2022.818167","article-title":"Association between cytomegalovirus and Epstein-Barr virus co-reactivation and hematopoietic stem cell transplantation","volume":"12","author":"Li","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025102314031200100_ofaf597-B4","doi-asserted-by":"crossref","first-page":"569381","DOI":"10.3389\/fimmu.2020.569381","article-title":"Viral infections in HSCT: detection, monitoring, clinical management, and immunologic implications","volume":"11","author":"Annaloro","year":"2020","journal-title":"Front Immunol"},{"key":"2025102314031200100_ofaf597-B5","doi-asserted-by":"crossref","first-page":"e13096","DOI":"10.1111\/tid.13096","article-title":"Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia","volume":"21","author":"Lin","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2025102314031200100_ofaf597-B6","doi-asserted-by":"crossref","first-page":"e12629","DOI":"10.1111\/tid.12629","article-title":"Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation","volume":"19","author":"Slade","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"2025102314031200100_ofaf597-B7","doi-asserted-by":"crossref","first-page":"620891","DOI":"10.3389\/fimmu.2020.620891","article-title":"Co-reactivation of cytomegalovirus and Epstein-Barr virus was associated with poor prognosis after allogeneic stem cell transplantation","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"2025102314031200100_ofaf597-B8","first-page":"556","article-title":"Cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation [in Chinese]","volume":"60","author":"Li","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2025102314031200100_ofaf597-B9","doi-asserted-by":"crossref","first-page":"e0228451","DOI":"10.1371\/journal.pone.0228451","article-title":"Viral reactivations following hematopoietic stem cell transplantation in pediatric patients\u2014a single center 11-year analysis","volume":"15","author":"D\u00fcver","year":"2020","journal-title":"PLoS One"},{"key":"2025102314031200100_ofaf597-B10","doi-asserted-by":"crossref","first-page":"e13719","DOI":"10.1111\/tid.13719","article-title":"Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant","volume":"23","author":"Lindsay","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2025102314031200100_ofaf597-B11","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"2025102314031200100_ofaf597-B12","doi-asserted-by":"crossref","first-page":"e13626","DOI":"10.1111\/tid.13626","article-title":"Clinical impact of multiple DNA virus infections in nondepleted haploidentical and unrelated allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Kerbauy","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2025102314031200100_ofaf597-B13","doi-asserted-by":"crossref","first-page":"619.e1","DOI":"10.1016\/j.jtct.2022.06.016","article-title":"Clinical and economic burden of multiple double-stranded DNA viral infections after allogeneic hematopoietic cell transplantation","volume":"28","author":"Hill","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2025102314031200100_ofaf597-B14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the Transplant Associated Virus Infections Forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025102314031200100_ofaf597-B15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox's regression model for counting processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"2025102314031200100_ofaf597-B16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/QCO.0000000000000888","article-title":"Risk factors and outcome of concurrent and sequential multiviral cytomegalovirus, Epstein-Barr virus, BK virus, adenovirus and other viral reactivations in transplantation","volume":"35","author":"Sim","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"2025102314031200100_ofaf597-B17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/jcm4030488","article-title":"Effects of T-cell depletion on allogeneic hematopoietic stem cell transplantation outcomes in AML patients","volume":"4","author":"Hobbs","year":"2015","journal-title":"J Clin Med"},{"key":"2025102314031200100_ofaf597-B18","doi-asserted-by":"crossref","first-page":"233.e1","DOI":"10.1016\/j.jtct.2023.11.015","article-title":"Opportunistic infections in patients receiving post-transplantation cyclophosphamide: impact of haploidentical versus unrelated donor allograft","volume":"30","author":"Little","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"2025102314031200100_ofaf597-B19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"key":"2025102314031200100_ofaf597-B20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbmt.2016.12.630","article-title":"Infectious risk after allogeneic hematopoietic cell transplantation complicated by acute graft-versus-host disease","volume":"23","author":"Miller","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025102314031200100_ofaf597-B21","first-page":"3135","article-title":"Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus","volume":"94","author":"Song","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2025102314031200100_ofaf597-B22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cid\/cix804","article-title":"Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell transplantation","volume":"66","author":"Hill","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025102314031200100_ofaf597-B23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bbmt.2017.06.008","article-title":"Co-infections by double-stranded DNA viruses after ex vivo T cell-depleted, CD34(+) selected hematopoietic cell transplantation","volume":"23","author":"Huang","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf597\/64425977\/ofaf597.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/10\/ofaf597\/64425977\/ofaf597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/10\/ofaf597\/64425977\/ofaf597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T18:03:20Z","timestamp":1761242600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf597\/8267732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf597","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,29]]},"article-number":"ofaf597"}}